Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $58 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on CVS Health and maintained a $58 price target.

July 23, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on CVS Health and maintained a $58 price target.
The reiteration of a Neutral rating and maintenance of the $58 price target suggests that the analyst does not foresee significant short-term changes in CVS Health's stock price. This neutral stance indicates stability but not necessarily growth or decline.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100